PROF. DR. WOLFRAM WIRBELAUER
partner, lawyer, professor of business law
Prof. Dr. Wolfram Wirbelauer is a trustberg partner and lawyer admitted to the German bar. Having studied at the universities of Mainz, Jena, Gießen, and Liverpool and received his Ph.D. in legal history, he has worked with major international organizations, such as PwC, KayeScholer, Covington & Burling, and BusinessEurope. At trustberg, Prof. Dr. Wirbelauer focuses on individual and collective labor law, compliance, and employee data protection law. He speaks English and German.
Vita
Law studies in Mainz, Jena, and Gießen
|
Studies in Business Administration in Liverpool
|
Admission to the German bar, 2009
|
Ph.D. in legal history, 2012
|
Appointment as Professor of Business Law, 2018
Focus
Individual and collective labor law
|
Compliance
|
Employee data protection law
|
Legal advice and court representation
Track Record
Legal assessment in German labor and social security law on a stock options plan drafted for a European telecommunication company
|
Representation of a medical center’s chief physician before the employment courts
|
Compliance investigation and legal assessment in industrial constitution law for an international software company
|
Dismissal protection trial representation for an executive employee of a supra-regional advertising agency
|
Drafting of a legal fact book as a part of a sales and purchase procedure concerning the purchase of a Dax 30 company´s international sub-companies
|
Legal advice and drafting of employee secondment contracts and corporate immigration procedures for an U.S. American global player in soft drink production and sales
|
Legal advice and drafting of termination agreements for the CEO of an Asian sub-company of a German pharmaceutical company
|
Legal due diligence assessment within a sale and purchase procedure concerning the acquisition of a group of hotels by an American investor
|
Dismissal protection trial for the head of compliance of an international weapons manufacturer
|
Negotiation of a company bargaining agreement for an international pharmaceutical company as part of a post-merger integration